ACE and hydrops fetalis: All HFrEF patients received standard HF treatment: 75 % of the patients received a beta-blocker, 62.5 % an angiotensin converting enzyme (ACE)-inhibitor, 87.5 % were on diuretics, 50 % were treated with an angiotensin II receptor antagonist and 75 % were on statin therapy.